Alternatives to animal testing: A review

The number of animals used in research has increased with the advancement of research and development in medical technology. Every year, millions of experimental animals are used all over the world. The pain, distress and death experienced by the animals during scientific experiments have been a debating issue for a long time. Besides the major concern of ethics, there are few more disadvantages of animal experimentation like requirement of skilled manpower, time consuming protocols and high cost. Various alternatives to animal testing were proposed to overcome the drawbacks associated with animal experiments and avoid the unethical procedures. A strategy of 3 Rs (i.e. reduction, refinement and replacement) is being applied for laboratory use of animals. Different methods and alternative organisms are applied to implement this strategy. These methods provide an alternative means for the drug and chemical testing, up to some levels. A brief account of these alternatives and advantages associated is discussed in this review with examples. An integrated application of these approaches would give an insight into minimum use of animals in scientific experiments.

[1]  M Gribskov,et al.  A systematic analysis of human disease-associated gene sequences in Drosophila melanogaster. , 2001, Genome research.

[2]  I Kimber,et al.  Alternative approaches to the identification and characterization of chemical allergens. , 2001, Toxicology in vitro : an international journal published in association with BIBRA.

[3]  M. Coye,et al.  NATIONAL RESEARCH COUNCIL AND INSTITUTE OF MEDICINE , 1998 .

[4]  C. Nichols,et al.  Human Disease Models in Drosophila melanogaster and the Role of the Fly in Therapeutic Drug Discovery , 2011, Pharmacological Reviews.

[5]  M. Barr,et al.  Super models. , 2003, Physiological genomics.

[6]  Richard E Peterson,et al.  Zebrafish as a model vertebrate for investigating chemical toxicity. , 2005, Toxicological sciences : an official journal of the Society of Toxicology.

[7]  J. Shay,et al.  The use of telomerized cells for tissue engineering , 2000, Nature Biotechnology.

[8]  J. Contrera,et al.  A new highly specific method for predicting the carcinogenic potential of pharmaceuticals in rodents using enhanced MCASE QSAR-ES software. , 1998, Regulatory toxicology and pharmacology : RTP.

[9]  T. Meredith,et al.  Principles and Practice of Ophthalmology , 1982 .

[10]  A M Goldberg,et al.  The Three Rs: The Way Forward , 1995, Alternatives to laboratory animals : ATLA.

[11]  Bernard E. Rollin,et al.  Toxicology and New Social Ethics for Animals , 2003, Toxicologic pathology.

[12]  K P Xu,et al.  Corneal organ culture model for assessing epithelial responses to surfactants. , 2000, Toxicological sciences : an official journal of the Society of Toxicology.

[13]  R. Nass,et al.  Caenohabditis elegans in Parkinson's disease drug discovery: addressing an unmet medical need. , 2008, Molecular interventions.

[14]  Joshua Chang Mell,et al.  Yeast as a Model Genetic Organism , 2003 .

[15]  U. Heberlein,et al.  Drugs, flies, and videotape: the effects of ethanol and cocaine on Drosophila locomotion , 2002, Current Opinion in Neurobiology.

[16]  Windy A. Boyd,et al.  Use of non-mammalian alternative models for neurotoxicological study. , 2008, Neurotoxicology.

[17]  C. Hendriksen,et al.  Replacement, reduction and refinement alternatives to animal use in vaccine potency measurement , 2009, Expert review of vaccines.

[18]  V. Baumans,et al.  Science-based assessment of animal welfare: laboratory animals. , 2005, Revue scientifique et technique.

[19]  W. Russell,et al.  Ethical and Scientific Considerations Regarding Animal Testing and Research , 2011, PloS one.

[20]  K. Strange.  Revisiting the Krogh Principle in the post-genome era: Caenorhabditis elegans as a model system for integrative physiology research , 2007, Journal of Experimental Biology.

[21]  Andrew D. Chisholm,et al.  Distinct Innate Immune Responses to Infection and Wounding in the C. elegans Epidermis , 2008, Current Biology.

[22]  C. Lesser,et al.  The Yeast Saccharomyces cerevisiae: a versatile model system for the identification and characterization of bacterial virulence proteins. , 2008, Cell host & microbe.

[23]  Emanuela Corsini,et al.  Alternative Methods for Skin Sensitisation Testing , 1996 .

[24]  Laurent Ségalat,et al.  High‐throughput screening and small animal models, where are we? , 2010, British journal of pharmacology.

[25]  H. Rockman,et al.  Drosophila melanogaster as a model system for genetics of postnatal cardiac function. , 2008, Drug discovery today. Disease models.

[26]  L. Gilbert,et al.  Drosophila is an inclusive model for human diseases, growth and development , 2008, Molecular and Cellular Endocrinology.

[27]  M. MacDonald,et al.  Polyglutamine-mediated dysfunction and apoptotic death of a Caenorhabditis elegans sensory neuron. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[28]  Coenraad F.M. Hendriksen,et al.  Three Rs achievements in vaccinology , 2008 .

[29]  B. Rusche.  The 3Rs and animal welfare - conflict or the way forward? , 2003, ALTEX.

[30]  Koichi M Iijima,et al.  Drosophila models of Alzheimer's amyloidosis: the challenge of dissecting the complex mechanisms of toxicity of amyloid-beta 42. , 2008, Journal of Alzheimer's disease : JAD.

[31]  Jonathan Balcombe,et al.  Animal Carcinogenicity Studies: 3. Alternatives to the Bioassay , 2006, Alternatives to laboratory animals : ATLA.

[32]  D G Dewhurst,et al.  Comparison of a computer simulation program and a traditional laboratory practical class for teaching the principles of intestinal absorption. , 1994, The American journal of physiology.

[33]  A Haverich,et al.  Tissue Engineering of Pulmonary Heart Valves on Allogenic Acellular Matrix Conduits: In Vivo Restoration of Valve Tissue , 2000, Circulation.

[34]  Michael Balls,et al.  Future improvements: replacement in vitro methods. , 2002, ILAR journal.

[35]  Susan E Wilson-Sanders,et al.  Invertebrate models for biomedical research, testing, and education. , 2011, ILAR journal.

[36]  Nancy M Bonini,et al.  Human neurodegenerative disease modeling using Drosophila. , 2003, Annual review of neuroscience.

[37]  Nektarios Tavernarakis,et al.  Caenorhabditis elegans: A versatile platform for drug discovery , 2006, Biotechnology journal.

[38]  I. J. Kuppast,et al.  A REVIEW ON ALTERNATIVES TO ANIMAL TESTING METHODS IN DRUG DEVELOPMENT , 2012 .

[39]  D McLeod,et al.  A simple organ culture model for assessing the effects of growth factors on corneal re-epithelialization. , 1996, Experimental eye research.

[40]  E. Herker,et al.  Apoptosis in yeast: a new model system with applications in cell biology and medicine , 2002, Current Genetics.

[41]  David H. Hall,et al.  Visualization of fibrillar amyloid deposits in living, transgenic Caenorhabditis elegans animals using the sensitive amyloid dye, X-34 , 2001, Neurobiology of Aging.

[42]  Lucília Saraiva,et al.  Contribution of Yeast Models to Neurodegeneration Research , 2012, Journal of biomedicine & biotechnology.

[43]  Angelo Vedani,et al.  [Computer-Aided Drug Design: An Alternative to Animal Testing in the Pharmacological Screening] , 1991, ALTEX.

[44]  T. Caquet,et al.  Invertebrates in testing of environmental chemicals: are they alternatives? , 1998, Environmental health perspectives.

[45]  Ann-Shyn Chiang,et al.  Dissecting the pathological effects of human Abeta40 and Abeta42 in Drosophila: a potential model for Alzheimer's disease. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[46]  W. Janzen,et al.  High Throughput Screening , 2016, Methods in Molecular Biology.

[47]  J Douglas Armstrong,et al.  Drosophila melanogaster--the model organism of choice for the complex biology of multi-cellular organisms. , 2005, Gravitational and space biology bulletin : publication of the American Society for Gravitational and Space Biology.

[48]  Ann-Shyn Chiang,et al.  Dissecting the pathological effects of human Aβ40 and Aβ42 in Drosophila: A potential model for Alzheimer's disease , 2004 .

[49]  M Balls,et al.  Replacement of animal procedures: alternatives in research, education and testing , 1994, Laboratory animals.

[50]  D. B. Roberts,et al.  Drosophila melanogaster: the model organism , 2006 .